NIE (Virtus AllianzGI Equitynvertibleome Fund) Research & Development: $0.0 Mil (TTM As of Jan. 2026)


NIE Virtus AllianzGI Equity & Convertible Income Fund NIE
53 GF Score
Price $26.43
GF Value $27.68
Valuation Fairly Valued
! 6 Warning Signs
View Full Analysis

What is Virtus AllianzGI Equitynvertibleome Fund Research & Development?

Virtus AllianzGI Equitynvertibleome Fund NIE -1.23% 53 Research & Development is $0.0 Mil as of Jan. 2026. GuruFocus rates NIE with a GF Score™ of 53/100 and a GF Value™ of $27.68 (Fairly Valued). The stock has 6 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Virtus AllianzGI Equitynvertibleome Fund's Research & Development for the six months ended in Jan. 2026 was $0.0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Jan. 2026 was $0.0 Mil.

Virtus AllianzGI Equitynvertibleome Fund  (NYSE:NIE) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Virtus AllianzGI Equitynvertibleome Fund Research & Development Related Terms

Virtus AllianzGI Equitynvertibleome Fund Research & Development Historical Data

* Premium members only.

The historical data trend for Virtus AllianzGI Equitynvertibleome Fund's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Virtus AllianzGI Equitynvertibleome Fund Research & Development Chart

Virtus AllianzGI Equitynvertibleome Fund Annual Data
Trend Jan18 Jan19 Jan20 Jan21 Jan22 Jan23 Jan24 Jan25 Jan26
Research & Development
Get a 7-Day Free Trial Premium Member Only 0.00 0.00 0.00 0.00 0.00

Virtus AllianzGI Equitynvertibleome Fund Semi-Annual Data
Jul17 Jan18 Jul18 Jan19 Jul19 Jan20 Jul20 Jan21 Jul21 Jan22 Jul22 Jan23 Jul23 Jan24 Jul24 Jan25 Jul25 Jan26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
NIE
53GF Score
Virtus AllianzGI Equity & Convertible Income Fund NIE
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Virtus AllianzGI Equitynvertibleome Fund Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Jan. 2026 adds up the semi-annually data reported by the company within the most recent 12 months, which was $0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of $0.0 Mil mean?
Virtus AllianzGI Equitynvertibleome Fund (NIE) has a Research & Development of $0.0 Mil as of Jan. 2026. Research and development expense is the total cost for research and development activities. View historical data on Virtus AllianzGI Equitynvertibleome Fund and its competitors.
Is Virtus AllianzGI Equitynvertibleome Fund's Research & Development too high?
Virtus AllianzGI Equitynvertibleome Fund's current Research & Development is $0.0 Mil. Overall, Virtus AllianzGI Equitynvertibleome Fund has a GF Score™ of 53/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Virtus AllianzGI Equitynvertibleome Fund's Research & Development compare to PFLT and MYI?
Virtus AllianzGI Equitynvertibleome Fund's Research & Development of $0.0 Mil can be compared against companies in the Asset Management industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for an Asset Management company?
A good Research & Development depends on the Asset Management industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Virtus AllianzGI Equitynvertibleome Fund and its competitors. Virtus AllianzGI Equitynvertibleome Fund's current Research & Development is $0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Virtus AllianzGI Equitynvertibleome Fund stock overvalued right now?
Based on GuruFocus' analysis, Virtus AllianzGI Equitynvertibleome Fund (NIE) is currently considered Fairly Valued. The stock's GF Value™ is $27.68, compared to a current price of $26.43 — trading 4.5% below its estimated fair value. The current Research & Development is $0.0 Mil. Virtus AllianzGI Equitynvertibleome Fund's overall GF Score™ is 53/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Virtus AllianzGI Equitynvertibleome Fund (NIE), the current Research & Development is $0.0 Mil as of Jan. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Virtus AllianzGI Equitynvertibleome Fund (NIE) Overvalued in 2026?

Based on GuruFocus' analysis, Virtus AllianzGI Equitynvertibleome Fund stock appears to be undervalued. The current stock price of $26.43 is trading 4.5% below its estimated GF Value™ of $27.68. GuruFocus considers Virtus AllianzGI Equitynvertibleome Fund to be Fairly Valued.

Key valuation signals for NIE:

  • Research & Development: $0.0 Mil
  • GF Value™: $27.68 vs. price of $26.43 (4.5% below fair value)
  • GF Score™: 53/100 with 6 warning signs

No single metric tells the full story. See the NIE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Virtus AllianzGI Equitynvertibleome Fund Business Description

Address 101 Munson Street, Greenfield, MA, USA, 01301-9683
Virtus AllianzGI Equity & Convertible Income Fund is a diversified, closed-end management investment company. The investment objective is to provide total return through a combination of current income, current gains and long-term capital appreciation. The fund pursues its objective by investing in a diversified portfolio of equity securities and income-producing convertible securities. Its portfolio of investments comprises different sector investments, such as aerospace and defense, banks, IT services, software, and others.
53GF Score

Get the complete analysis for NIE

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$26.43
Price
$27.68
GF Value